Isolation and Characterization of Cyclo-(tryptophanyl-prolyl) and Chloramphenicol from Streptomyces Sp. SUK 25 with Antimethicillin-resistant Staphylococcus Aureus Activity

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2016 Jun 23

PMID 27330275

Citations 6

Authors

Muhanna M Alshaibani

Juriyati Jalil

Nik M Sidik

RuAngelie Edrada-Ebel

Noraziah M Zin

Affiliations

Soon will be listed here.

Abstract

Background: Zingiber spectabile, commonly known as Beehive Ginger, is used as an ethnobotanical plant in many countries as an appetizer or to treat stomachache, toothache, muscle sprain, and as a cure for swelling, sores and cuts. This is the first report of isolation of Streptomyces strain from the root of this plant. Strain Universiti Kebangsaan 25 (SUK 25) has a very high activity to produce secondary metabolites against methicillin-resistant Staphylococcus aureus (MRSA), which is associated with high morbidity and mortality rates due to acquired multidrug resistance genes and causes medication failure in some clinical cases worldwide. Phylogenetic analysis based on the 16S ribosomal RNA gene sequence exhibited that the most closely related strain was Streptomyces omiyaensis NBRC 13449T (99.0% similarity).

Aim: This study was conducted to carry out the extraction, identification, and biological evaluation of active metabolites isolated from SUK 25 against three MRSA strains, namely, MRSA ATCC 43300, MRSA ATCC 33591, and MRSA ATCC 49476.

Materials And Methods: The production of secondary metabolites by this strain was optimized through Thronton's media. Isolation, purification, and identification of the bioactive compounds were carried out using reversed-phase high-performance liquid chromatography, high-resolution mass spectrometry, Fourier transform infrared, and one-dimensional and two-dimensional nuclear magnetic resonance.

Results: During screening procedure, SUK 25 exhibited good antimicrobial potential against several strains of MRSA. The best biological activity was shown from fraction number VII and its subfractions F2 and F3 with minimum inhibitory concentration values at 16 µg/mL and 8 µg/mL, respectively. These two subfractions were identified as diketopiperazine cyclo-(tryptophanyl-prolyl) and chloramphenicol.

Conclusion: On the basis of obtained results, SUK 25 isolated from Z. spectabile can be regarded as a new valuable source to produce secondary metabolites against bacteria, especially MRSA.

Citing Articles

Antimicrobial Action Mechanisms of Natural Compounds Isolated from Endophytic Microorganisms.

Eshboev F, Mamadalieva N, Nazarov P, Hussain H, Katanaev V, Egamberdieva D Antibiotics (Basel). 2024; 13(3).

PMID: 38534706 PMC: 10967585. DOI: 10.3390/antibiotics13030271.

Antimicrobial potentials of natural products against multidrug resistance pathogens: a comprehensive review.

Elmaidomy A, Shady N, Abdeljawad K, Elzamkan M, Helmy H, Tarshan E RSC Adv. 2022; 12(45):29078-29102.

PMID: 36320761 PMC: 9558262. DOI: 10.1039/d2ra04884a.

Biodiversity of Secondary Metabolites Compounds Isolated from Phylum Actinobacteria and Its Therapeutic Applications.

Al-Shaibani M, Mohamed R, Sidik N, Enshasy H, Al-Gheethi A, Noman E Molecules. 2021; 26(15).

PMID: 34361657 PMC: 8347454. DOI: 10.3390/molecules26154504.

Enhanced Pharmaceutically Active Compounds Productivity from SUK 25: Optimization, Characterization, Mechanism and Techno-Economic Analysis.

Al-Shaibani M, Mohamed R, Mohamad Zin N, Al-Gheethi A, Al-Sahari M, Enshasy H Molecules. 2021; 26(9).

PMID: 33923072 PMC: 8123281. DOI: 10.3390/molecules26092510.

as a Prominent Resource of Future Anti-MRSA Drugs.

Mangzira Kemung H, Tan L, Khan T, Chan K, Pusparajah P, Goh B Front Microbiol. 2018; 9:2221.

PMID: 30319563 PMC: 6165876. DOI: 10.3389/fmicb.2018.02221.

References

Berdy J . Bioactive microbial metabolites. J Antibiot (Tokyo). 2005; 58(1):1-26. DOI: 10.1038/ja.2005.1. View

Strobel G, Daisy B . Bioprospecting for microbial endophytes and their natural products. Microbiol Mol Biol Rev. 2003; 67(4):491-502. PMC: 309047. DOI: 10.1128/MMBR.67.4.491-502.2003. View

Gao B, Gupta R . Phylogenetic framework and molecular signatures for the main clades of the phylum Actinobacteria. Microbiol Mol Biol Rev. 2012; 76(1):66-112. PMC: 3294427. DOI: 10.1128/MMBR.05011-11. View

Ehrlich J, BARTZ Q, Smith R, JOSLYN D, BURKHOLDER P . Chloromycetin, a New Antibiotic From a Soil Actinomycete. Science. 1947; 106(2757):417. DOI: 10.1126/science.106.2757.417. View

Saitou N, Nei M . The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987; 4(4):406-25. DOI: 10.1093/oxfordjournals.molbev.a040454. View

Coombs J, Franco C . Isolation and identification of actinobacteria from surface-sterilized wheat roots. Appl Environ Microbiol. 2003; 69(9):5603-8. PMC: 194995. DOI: 10.1128/AEM.69.9.5603-5608.2003. View

Park Y, Gunasekera S, Lopez J, McCarthy P, Wright A . Metabolites from the marine-derived fungus Chromocleista sp. isolated from a deep-water sediment sample collected in the Gulf of Mexico. J Nat Prod. 2006; 69(4):580-4. DOI: 10.1021/np058113p. View

Rajan B, Kannabiran K . Extraction and Identification of Antibacterial Secondary Metabolites from Marine Streptomyces sp. VITBRK2. Int J Mol Cell Med. 2014; 3(3):130-7. PMC: 4170486. View

Siti Junaidah A, Suhaini S, Sidek H, Basri D, Mohamad Zin N . Anti-Methicillin Resistant Staphylococcus aureus Activity and Optimal Culture Condition of Streptomyces sp. SUK 25. Jundishapur J Microbiol. 2015; 8(5):e16784. PMC: 4458357. DOI: 10.5812/jjm.16784. View

10.

French G . Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. J Antimicrob Chemother. 2006; 58(6):1107-17. DOI: 10.1093/jac/dkl393. View

11.

Cha J, Park Y, Lee Y, Chung G . In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea. Diagn Microbiol Infect Dis. 2011; 70(1):112-8. DOI: 10.1016/j.diagmicrobio.2010.11.018. View

12.

Prasad C . Bioactive cyclic dipeptides. Peptides. 1995; 16(1):151-64. DOI: 10.1016/0196-9781(94)00017-z. View

13.

Zin N, Sarmin N, Ghadin N, Basri D, Sidik N, Hess W . Bioactive endophytic streptomycetes from the Malay Peninsula. FEMS Microbiol Lett. 2007; 274(1):83-8. DOI: 10.1111/j.1574-6968.2007.00819.x. View

14.

McKee E, Ferguson M, Bentley A, Marks T . Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother. 2006; 50(6):2042-9. PMC: 1479116. DOI: 10.1128/AAC.01411-05. View

15.

McCormick J, Flardh K . Signals and regulators that govern Streptomyces development. FEMS Microbiol Rev. 2011; 36(1):206-31. PMC: 3285474. DOI: 10.1111/j.1574-6976.2011.00317.x. View

16.

Nishanth Kumar S, Mohandas C, Nambisan B . Purification, structural elucidation and bioactivity of tryptophan containing diketopiperazines, from Comamonas testosteroni associated with a rhabditid entomopathogenic nematode against major human-pathogenic bacteria. Peptides. 2013; 53:48-58. DOI: 10.1016/j.peptides.2013.09.019. View

17.

Tamura A, Takeda I, Naruto S, Yoshimura Y . Chloramphenicol from Streptosporangium viridogriseum var. kofuense. J Antibiot (Tokyo). 1971; 24(4):270. DOI: 10.7164/antibiotics.24.270. View

18.

Mosher R, Camp D, Yang K, Brown M, Shaw W, VINING L . Inactivation of chloramphenicol by O-phosphorylation. A novel resistance mechanism in Streptomyces venezuelae ISP5230, a chloramphenicol producer. J Biol Chem. 1995; 270(45):27000-6. DOI: 10.1074/jbc.270.45.27000. View

19.

Konate K, Mavoungou J, Lepengue A, Aworet-Samseny R, Hilou A, Souza A . Antibacterial activity against β- lactamase producing Methicillin and Ampicillin-resistants Staphylococcus aureus: Fractional Inhibitory Concentration Index (FICI) determination. Ann Clin Microbiol Antimicrob. 2012; 11:18. PMC: 3464800. DOI: 10.1186/1476-0711-11-18. View

20.

Cho S, Choi Y, Simkhada J, Mander P, Park D, Yoo J . A newly isolated Streptomyces sp. CS392 producing three antimicrobial compounds. Bioprocess Biosyst Eng. 2011; 35(1-2):247-54. DOI: 10.1007/s00449-011-0599-7. View